COVID

Collaborators

Leaders in drug development offering expert, discounted, and pro-bono services to accelerate treatments and vaccines in the global fight against COVID-19.

View Offerings
Offering type
Category
166 results
Posted Friday, October 23
PRC Clinical - Right for Your Research
PRC Clinical has specialized in providing specialty CRO services since 2003. For biotech and pharmaceutical companies, our innovative approach to executing studies combines high-touch human elements and cutting-edge technology with extensive experience and deep therapeutic knowledge. PRC Clinical has specialized expertise across COVID-19, regenerative medicine, CNS, ophthalmology, pulmonary, rare & orphan disease, and more specialty areas. Along with our host of online management tools, we ensure your trial receives the TLC it deserves from PRC.
Contact
Posted Monday, August 24
Roylance Pharma offers a secure offsite bio storage facility for all your COVID-19 storage and distribution needs
Roylance Pharma are a specialist secure and licenced offsite bio storage facility, we offer conditions including LN2, -80ºC, -20ºC, 5ºC & controlled ambient to store your COVID-19 related samples and vaccines. With capacity to store over 1,000 -80ºC freezers we are here to support the on-going COVID-19 studies and vaccine manufacture.
Contact
Posted Tuesday, August 18
Alderley Analytical offers Non-regulatory and Regulatory Bioanalytical Services to support COVID-19 preclinical and clinical studies.
Alderley Analytical is a state of the art GLP and GCP compliant bioanalytical laboratory offering a full bioanalytical service to provide a solution for your Pharmacokinetic / exposure / biomarker endpoints.
Contact
Posted Wednesday, July 29
Ephicacy offers discounted, best-in-class biostatistics and statistical programming to support sponsors in their fight against COVID-19
We provide discounted, best-in-class biostatistics and statistical programming services by our expert team using validated tools in a secure environment. We are currently providing services to a pharma company related to COVID study and we would be glad to extend our services at a discounted pricing to organizations in our support to fight against this pandemic. • Ephicacy has been a trusted clinical service provider for several major pharma, bio-tech companies offering data-oriented services including clinical data management, statistical programming and end-to-end biostatistics services using licensed SAS v9.4 software powered by robust processes and secure computing environment ensuring compliance in meeting the regulatory needs. • Our expert team of biostatisticians and statistical programmers are experienced in handling various phases, therapeutic areas including vaccines and medical device projects.
Contact
Posted Tuesday, July 21
Algorics offers a complimentary review of new and ongoing protocols for COVID-19 clinical trials, to assess if they are robust to the data processing and statistical challenges presented by the pandemic
Algorics is offering a free protocol review to support early stage biopharma customers who are designing and running COVID-19 trials. Early stage biotech sponsors who are not sure how the COVID-19 pandemic could impact their new or ongoing trials, for example the consequences of the missing patient data, will benefit from an independent review of their protocol. What is included in the analysis? • Statistical review of COVID-19 protocols for the impact of the pandemic on the capture and analysis of data – with a focus on safety data • Recommendations on how to update the protocol and suggested areas to monitor as the trial progresses
Contact
Posted Tuesday, July 14
Integrated drug discovery partner with extensive small molecule virology experience targeting drug delivery by oral or inhalation routes
Delivered two respiratory related compounds to clinical trials and two preclinical assets. Recent projects include identifying, synthesising, testing and optimising molecules to accelerate potential Covid-19 treatments to the clinic. Sygnature Discovery, a leading integrated drug discovery CRO, offers a range of services across medicinal and computational chemistry, in vitro and in vivo pharmacology as well as DMPK. Since 2011, 31 compounds discovered by Sygnature have entered pre-clinical development; so far, 15 of these have progressed to clinical trials.
Contact
Posted Friday, June 26
COVID Antigens and free Transposase licenses
As a key supplier for the urgent development of COVID-19 diagnostics, vaccines and therapeutics, ATUM has been working around the clock on custom projects and now offers off-the-shelf catalog reagents. By applying the ATUM gene synthesis platform, mammalian protein production and Leap-In Transposase® mediated Cell Line Development, ATUM accelerates your development with both custom and ready-to-ship reagents.
Contact
Posted Monday, June 15
ConvergeHEALTH by Deloitte Waives Licensing Fees for MyPath for Clinical for COVID and COVID-Impacted Trials
To support the life sciences industry now facing challenges conducting clinical trials during the COVID-19 pandemic, ConvergeHEALTH by Deloitte today announced it is waiving all licensing fees for MyPath for Clinical for current COVID-19 related clinical trials, as well as any current clinical trial impacted by COVID-19. MyPath for Clinical is a cloud-based digital platform designed to enhance the patient experience as well as the success and efficiency of global clinical trials.
Contact
Posted Monday, May 25
Accelsiors CRO provides a full-service support for COVID-19 studies, having hands-on insight about centers, patient availability and accelerated regulatory approval process
As a full-service, global and scientifically oriented CRO, Accelsiors has been managing phase 1 to phase 3 clinical trials since 2002. Operating in more than 40 countries across 5 continents, we are supporting studies from protocol design and statistical input, through study management and monitoring until submission for marketing authorization. Broad experience with Vaccines, Respiratory and Infectious diseases indications. Currently conducting COVID-19 studies, we have deep understanding of the outbreak circumstances and status of COVID-19 centers and hospitals, as well as access to the patients in all affected regions, both in Europe and US. Direct experience with accelerated regulatory approval, which allows us to conduct all the start-up activities within a minimal time frame. With implementation of our proven methodologies which contain elements of Remote monitoring as well as Central Monitoring (i.e. data analytics), and Risk-based monitoring with partial SDV, we are focusing on the critical data, allowing us to efficiently detect any discrepancies and potential risks at the site level.
Contact
Posted Monday, May 25
SubjectWell is offering free access to our registry of volunteers for COVID-19 trials, a growing patient registry of individuals in the US interested in participating in clinical trials for a COVID-19 vaccine as these trials become more widely available
With SubjectWell’s COVID-19 patient registry, researchers will have access to interested individuals who could randomize for various types of trials, whether they are healthy volunteers with no previous exposure to COVID-19, currently sick with the virus, or those who have recovered. Patient data includes general demographic information, existing medical conditions, past virus diagnoses, past exposure to the virus and results of positive antigen tests. This free access gives researchers the ability to sidestep the lengthy process of identifying participants for a clinical trial. The list will dramatically accelerate last patient in (LPI), which could ultimately bring a safe, approved vaccine to the general public faster.
Contact
Posted Friday, May 22
Digital Twin - personalized PKPD modeling to secure and fasten drug repurposing against Covid-19
ExactCure's "Digital Twin" provides personalized PKPD simulations of new or repurposed drugs based on patient's characteristics (age, weight, renal status, genotype, etc.). We help spot outliers early during clinical trials in phases 2b & 3, thereby reducing attrition rate. Later we can provide a "Digital Companion" to the marketed drug ("Beyond the pill" services + get Real World Evidence + correlate Patient Reported Outcomes to the blood concentration of the drug). The goal is to avoid under-doses, overdoses and drug-drug interactions, as well as to improve adherence. For Covid-19, we have released personalized simulators of lopinavir/ritonavir, hydroxychloroquine, paracetamol. Tocilizumab and a few others are almost ready. We are working on 15 additional drugs with Elsevier’s PharmaPendium®.
Contact
Posted Friday, May 22
SAS launches free AI-driven environment to mine COVID-19 research
Globally, thousands of scientists are working tirelessly on COVID-19 mitigation efforts, including the search for new treatments and a vaccine. Analytics leader SAS brings a powerful resource to the fight with COVID-19 Scientific Literature Search and Text Analysis, a free visual text analysis environment that uses artificial intelligence (AI) and machine learning to quickly search tens of thousands of research articles on COVID-19 and deliver potentially lifesaving answers to these scientists.
Contact
Posted Wednesday, May 20
COVID-19 Drug Development, vaccine and diagnostic kits development services
At Labtoo, we are Experts in outsourcing R&D project management. We are working with more than 500 partners across Europe, providing services in discovery, preclinical R&D and regulatory testing. A specific version of our matching platform was developed during the crisis. We also started a dedicated COVID-19 concierge service aiming to support Biotech companies in their outsourcing processes: 1) Validation of project. 2) CRO or Academic Lab identification. 3) Support for the contracting process: quotation, IP, CDA, MTA, etc. 4) Negotiation.
Contact
Posted Tuesday, May 19
Expert statistical support and analytical consultancy - at discounted rates
Despite the globally felt urgency to find a cure for COVID-19, it is imperative that studies adhere to scientific methods and the resultant data are analysed in a scientifically sound way, generating robust statistical evidence. Protocol development and study set up, tasks that would normally take months, need now to be accomplished in weeks. Supporting such rapid study start up requires statisticians with expert skills, experience and flexibility. If you need statistical help with protocol development, interim analysis or DSMBs you can count on Numerus’s team of statisticians, programmers and epidemiologists to support you. We are here to help, and happy to share our knowledge and expertise in clinical statistics and analytical methodology.
Contact
Posted Thursday, May 14
UK consortium launches COVID-19 Protein Portal to provide essential reagents for SARS-CoV-2 research
A new initiative, led by Wellcome and UKRI, will allow UK scientists to access protein reagents needed for critical research relating to SARS-CoV-2 free of charge from a consortium of leading protein production laboratories.
Contact
Posted Tuesday, May 12
Cloud-based platform for automated analysis of COVID-19 NGS data
Flomics has joined forces with international biotech partners, specialized in Next Generation Sequencing tests, to develop a cloud-based data analysis solution for COVID19 detection and research. Combining the unique features of the different experimental sequencing kits available for SARS-CoV-2 detection (either metagenomics or amplicon based), we maximize the information extracted from each single experiment performed in a reliable, sensitive and automated way. Our platform helps hospitals, clinics and research laboratories in transforming raw data into interpretable clinical information that will help manage this pandemic, without the need for computational infrastructures or bioinformatics expertise.
Contact
Posted Monday, May 11
Free Encapsia software licenses for COVID-19 studies and any assigned resources and hosting costs can be provided on a Not For Profit basis
Encapsia is purpose-built for modern, smart, clinical trials with fast database build, flexible data capture and loading options, plus live visualizations of aggregated data to deliver technical data science to our customers. Clinical Trials involving hospitalized COVID-19 patients present unique challenges. Encapsia addresses these by enabling collection of clinical trial data via eSource on an iPad – easy to use for bedside data capture under strict infection management, where access to conventional data capture devices is limited. EDC and lab data are also collected into the same database in real-time. Inbuilt, visualizations of live trial data and metadata provide rapid feedback for stakeholders and the study team for faster decision-making. We are committed to rapidly build and deploy study databases for COVID-19 trials. We will flexibly partner with any organisation in the common fight against COVID-19 and provide encapsia via software as a service. Cmed Technology is the developer of encapsia, an innovative, powerful, next-generation clinical data suite. Learn more by clicking the link below.
Contact
Posted Friday, May 8
Offering Arcinova’s experience and expertise in accelerating the development and manufacture of potential treatments for COVID-19
Arcinova can help fast-track the scientific and industrial response to the COVID19 pandemic. With a single site covering drug substance, formulation, drug product, analytical and bioanalytical expertise, we are well positioned to accelerate pharmaceutical development with limited tech transfer delays. We have prior experience in developing anti-virals medicines, including the bioanalysis of patient samples containing highly infectious agents (we have both BSL3 and BSL2 labs in our facility).
Contact
Posted Wednesday, May 6
Free viral epitopes visualization tool and AI-powered platforms
Ardigen is a Life Science computational partner in the era of Artificial Intelligence. We provide comprehensive services that leverage our domain knowledge and expertise in bioinformatics, machine learning and software engineering together with our proprietary technology. We are offering: 1) Free of charge tool - visualizes the SARS-CoV-2 virus proteome structure and allows to display identified viral epitopes on the corresponding regions of the virus. 2) Customized, in silico drug discovery tools - enable improved drug development and data analysis utilizing bioinformatics and AI-powered approaches e.g small RNA design platform, computer vision algorithms, drug repurposing and virtual screening models, drug properties prediction model, drug efficacy and efficiency prediction with a statistical learning approach. 3) Microbiome Translational Platform - enables a novel, powerful approach to the design and development of microbiome-derived therapeutics and diagnostics. 4) ArdImmune Vax Platform - enables a unique approach to selecting immunogenic epitopes for viral vaccines, as well as cancer vaccines and adoptive cell therapies development targeting shared and personalized neoantigens.
Contact
Posted Wednesday, May 6
Smart COVID-19 clinical trial search
Antidote Match is the first trial matching engine that uses structured eligibility criteria (using industry standard and custom-designed ontologies) and proprietary algorithms to explore a patient’s eligibility for every trial. When searching COVID-19 trials, patients answer a handful of questions about their health, and the Antidote Match engine traverses all COVID-19 trials in ClinicalTrials.gov, regardless of location, to connect them with the right studies. This search technology is offered free of charge on Antidote's website and the websites of 250+ patient-facing organizations and nonprofits.
Contact
Posted Friday, May 1
Covid Clinical Coldchain Compliance
va-Q-tec offers reliable, high perfomance single use and pay-per-use cold chain packaging solutions to maintain temperature stability during transportation and handling. Deep frozen, refrigerated and CRT temperature ranges are part of our worry-free, passive cold chain solutions. Please call or email us for a Free consultation specifically for your emerging Covid 19 clinical trials developments.” (insert contact info. here) Specific to Covid 19 many new R&D projects and clinical trials are launching. Sponsors, CMO's , CDMO's and others use our cold chain packaging to insure quality and regulatory compliance when shipping to sites. If you’d like to discuss how to maintain a compliant cold chain, you may contact [email protected] M: (267) 858-1865 with your emerging Covid 19 clinical trials developments or temperature controlled test kit shipment packaging needs.
Contact
Posted Friday, May 1
TransPerfect Life Sciences Announces Free Access To Trial Interactive Central And Remote Monitoring Solutions For Study Teams Impacted By COVID-19
In response to COVID-19, TransPerfect is offering access to Trial Interactive's Study Document Collaboration and myTI mobile application free of charge: 1) A central, shared workspace and portal with secure, 21 CFR Part 11 compliant access 2) Storage of redacted subject source documents 3) Access for all CRAs to do remote and central monitoring 4) A mobile app and workspace that enables site personnel to directly submit subject records to the site portal 5) A dedicated study email to send documents to the portal inbox 6) An iOS and Android mobile app, myTI, to scan documents and directly upload them to the study portal 7) Access to controlled direct upload by site personnel where only their respective site files can be viewed 8) The ability to fax documents directly to the portal
Contact
Posted Thursday, April 30
Career advice and help finding a job at a company working on COVID-19
Barrington James is a global life science recruitment consultancy, we specialise in helping life science professionals plan their careers and help them find the perfect next role. During these challenging times we would be happy to provide advice and support. Whether you have been made redundant and need a new role or are motivated to move to a company that is working to help solve Covid-19.
Contact
Posted Thursday, April 30
CAS releases open access dataset of antiviral chemical compounds to aid COVID-19 discovery and analysis
CAS, a division of the American Chemical Society specializing in scientific information solutions, is partnering with research and technology organizations worldwide to tackle the complex challenges presented by COVID-19. In support of calls to action from the White House Office of Science and Technology Policy and innovation leaders around the globe, CAS just released an open access dataset of chemical compounds with known or potential antiviral activity to support research, data mining and analytics applications.
Contact
Posted Monday, April 27
ClinCloud is supporting COVID-19 clinical research and virtual screenings via ClinCloud's Memoirs mobile app
ClinCloud Clinical Research site is fully staffed and operational during the COVID-19 pandemic. We are on-board to accelerate finding treatments, improved testing, and investigational vaccines. We continue to see patients in-clinic that are currently enrolled in a research study. We are dedicated to following the guidelines from the CDC, Florida Department of Health, and health care advisers, to process updates and plan strategies for our clinic. ClinCloud has taken a series of steps to maintain a level of hygiene and cleanliness for the health of the people we serve and our employees. During this time of COVID-19, we see the importance of clinical research and how it remains a priority. We will continue to provide quality services and support the people we serve during this challenging time. This may include virtual visits, phone visits, and more. The ClinCloud team is dedicated to offering new and innovative solutions for our community and fellow research sites. We continue pre-screening prospective patients virtually with the ClinCloud Memoirs mobile app. available on both Android and iOS.
Contact
Posted Monday, April 27
IBM offering free access to patent portfolio to combat COVID-19
In the spirit of such innovation, IBM, the leading U.S. patent recipient for each of the last 27 years, is granting free access to its considerable patent portfolio to those developing technologies to help diagnose, prevent, contain or treat coronaviruses, including the one that causes COVID-19. Our pledge covers thousands of IBM AI patents, including Watson technology patents, as well as dozens of active U.S. patents in the general area of biological viruses.
Contact
Posted Thursday, April 23
Firma Clinical Research offers home health visits for COVID-19 study participants
Firma Clinical’s Home Health Visits are helping provide continuity for COVID-19 studies. Firma offers in-home and alternative location services for study participants, and we are aligned with the latest FDA, NHS and EMA guidelines for patient safety and data protocols for clinical trials during public health emergencies like COVID-19. Firma is committed to a patient-centric approach that supports positive outcomes in the drug development process. Our Home Health Visits advance safety measures, minimize burden, improve retention and maximize protocol compliance. We also are ready to advance new decentralized research with a home health component.
Contact
Posted Tuesday, April 21
LKF provides services for the analysis of Coronavirus (SARS-COV-2-PCR and antibody tests)
LKF – Laboratorium für Klinische Forschung, member of GBA Group Pharma, was founded in 1991 and has more than 25 years of experience as a specialized medical laboratory supporting clinical trials of phase I-IV. Scientific advice, generation of trial specific lab manuals, provision of study specific lab kits, organization of worldwide kits and specimen logistics and a comprehensive analytical service (safety panel, biomarkers, PK) are our core competencies. With the implementation of the new assays for the detection of SARS-COV-2 by PCR and the respective antibody tests we are ready for your COVID-19 trial. All services are performed in house enabling a professional, flexible and fast approach. This allows us to set-up a COVID-19 trial within one week from receiving the clinical trial protocol until delivery of lab kits to the intensive care units.
Contact
Posted Friday, April 17
Clinion is happy to offer discounted Clinion platform licenses for Covid 19 studies to support the global race for a COVID-19 treatment/vaccine
Clinion is a validated, Robust and Secure e-Clinical platform designed to Optimize User Experience by integrating operations and data management and providing state-of-the-art analytics. For additional information, please visit http://www.clinion.com or contact us at [email protected]
Contact
Posted Friday, April 17
Full service CRO with 40 bed cpu for COVID-19 vaccine and diagnostic trials
Located in the NY/NJ metro area, TKL Research has unwillingly been placed in a COVID-19 epicenter, and we are doing our part to assist and combat this virus by any means necessary. While our own principal investigators are battling the virus on the front lines at hospitals nearby, we have a 40 bed pharmacology unit, four outpatient clinics, thousands of healthy volunteers and vaccine experience. In this rapidly evolving pandemic, our leadership team meets daily to stay informed on the ever-changing safety protocols in order to keep our studies running smoothly and our volunteers healthy. We are positioned to be the best fit for a phase I vaccine trial or other COVID-19 treatment alternatives. We have the ability to run your phase I study and carry it through to it’s final approval with our full service CRO capabilities and highly experienced team. We are focused, flexible and able to swiftly make changes in order to meet study requirements and changing safety guidelines. We are your solution.
Contact
Posted Thursday, April 16
ASKE Solutions is ready to provide clinical research and logistical support services to help in the fight against COVID-19
Based in central Texas, ASKE Solutions, LLC provides a variety of support services for clinical trials around the world. We specialize in biological sampling kit design, assembly and distribution, Investigational Product blinding, repackaging, storage and distribution, and biological specimen and retention sample storage. We want to help and are offering our services in support of projects targeting COVID-19 at a reduced rate. Please contact us at [email protected]
Contact
Posted Wednesday, April 15
Elligo Health Research offering patient access solutions
As the ultimate healthcare-enabling research organization, the mission of Elligo Health Research has always been to bring clinical research directly to clinical healthcare, solving patient access challenges by enabling research as a care option. We have been project-managing and staffing drive-thru COVID-19 test sites since mid-March. With access to over two million patients, Elligo has approved efforts to support vaccines, treatment, and testing across our community of sites. Currently, various sites within our network have been at the epicenter of the outbreak and through our existing capabilities, we immediately expanded our efforts to provide solutions to contribute to ongoing, crucial efforts to fight the COVID-19 pandemic: 1) Decentralized or hybrid model for clinical research 2) Full and secure remote monitoring capabilities powered by our proprietary eSource/CTMS platform, IntElligo Research Stack™ Technology 3) Access to diverse patient pools including less populated areas with a high potential of COVID-19 cases and areas with no current access to testing 4) Centralized, remote chart review to minimize patient interaction, operationalize the study, and conduct patient identification 5) Trial Oversight: Elligo’s project leadership, made up of experienced Project Management (PM) and Project Director (PD) staff ensure consistency in trial execution and clarity in sponsor communication, including consistent training for all sites in the network
Contact
Posted Wednesday, April 15
CRMG offers clinical operations expertise during the COVID-19 pandemic
Since 1997, CRMG has provided biotech and pharma companies with tailored support for all phases of clinical development. During this unprecedented time, we offer our expertise to those working toward solutions for the COVID-19 pandemic. We offer a wide range of clinical operations and regulatory support, with internal experts and a broad network of qualified consultants. Our services include: 1) Study Start Up - Available services include protocol development, site identification & feasibility, site start-up & training. Our emphasis is on quality and speed, getting your trial up and running ASAP. 2) Study Conduct - Available services include project management, clinical monitoring, and site management. During this uncertain time, our experience with remote clinical monitoring is particularly valuable, including already developed plans, procedures & templates to support GCP-compliant remote clinical monitoring. 3) Study Close-out - site payments, IP accountability, and regulatory auditing. CRMG ensures that your study remains FDA and GCP compliant throughout, and ends with thorough quality control of your records. 4) Drug Distribution - CRMG's top of the line drug distribution center is housed on-site and includes temperature & humidity controlled ambient, refrigerated, and frozen storage, with environmental monitoring, alarms, and back up generator. Drug distribution turnaround time is 24 hours.
Contact
Posted Tuesday, April 14
Free patient recruitment support
Finding participants for COVID-19 clinical trials quickly is crucial. No one can afford slow patient recruitment. As a leader in patient recruitment, Patient Advertising Guru is seeking opportunities to help by offering our services at no cost. We will waive our fees for any project to find participants for any COVID-19-related clinical trial (testing, vaccine, treatment, etc.). Whether it be traditional advertising (television, radio, print) or online (search marketing, social media, Hulu, etc.) or any marketing initiative, Guru has the expertise to assist and we will charge no fees.
Contact
Posted Tuesday, April 14
We at Viedoc Technologies would be happy to be a part of accelerating the development of treatments for COVID-19
To help increase the speed of vaccine research, we have put together an offer to reduce barriers in the race for a vaccine. We know Viedoc is perfectly matched to the challenge for fast and flexible set-ups and with solutions that are famously easy to learn. The COVID-19 pandemic has quickly become the world's greatest challenge. Viedoc Technologies is here to face that challenge together with the scientific community by waving ordinary license fees. Viedoc is a comprehensive cloud-based platform built to improve the efficiency of conducting clinical trials. EDC, RTSM, and ePRO services are part of the Viedoc eClinical suite. Since 2003 Viedoc has been used in over 2 000 trials in more than 70 countries in all therapeutic areas and clinical phases. Created by industry professionals with decades of experience, Viedoc blends innovation with design to simplify your workday. Our mission is to be at the forefront of eClinical innovation by developing new, smarter ways to help all our clients succeed. Viedoc meets all applicable regulatory standards, including ICH GCP, 21 CFR part 11, and HIPAA. Viedoc Technologies has offices around the world. With our headquarters in Uppsala, Sweden, we also have offices in Philadelphia, Tokyo and Shanghai.
Contact
Posted Tuesday, April 14
Biocatalyst4Development (B4D) offers expertise to support drug development for COVID-19 therapeutics and diagnostics
With over 25 years experience in all aspects of drug development, including preclinical, clinical/regulatory and chemistry and manufacturing we are offering our services to assist Canadian companies seeking to rapidly advance promising COVID-19 therapies into clinical trials. We can leverage our experience working with clinical investigators and CROs for protocol design and study execution, data management and statistics. We also have experience working with contract manufacturers for GMP manufacture of clinical supplies, analytical and bioanalytical method development.
Contact
Posted Tuesday, April 14
D3 Clinical Research Partners is offering Reduced Rates for All Services and Rapid Start-up Guarantee
D3 Clinical Research Partners is a Full Service CRO that excels on execution, quality and collaboration. In this challenging environment you need a partner that you can trust and rely on that they will get it right the FRIST time as so many lives are at stake.D3 is a consortium of industry veterans with a 20 year working together successfully history.
Contact
Posted Tuesday, April 14
Bio-Optronics is offering free use of its leading cloud-based CC CTMS (Clinical Trial Management System) to immediately help research sites conducting COVID-19 trials
Bio-Optronics is committed to supporting COVID-19 research and is offering free use to those that don’t already have access to the most widely used CTMS by sites in the world. As you work hard to bring new COVID-19 diagnostics or treatments to market, we are offering free use of CC CTMS to support studies focused on this pandemic and to help ensure they conclude as efficiently as possible. Being cloud-based, it is also ideal for enabling remote work if needed. New users conducting qualifying studies will be entitled to utilize our robust clinical trial management system (CTMS) for the entirety of your COVID-19 studies. Setting up CC CTMS is easy, and our service teams will quickly deploy CC CTMS and train your team (via live and recorded online learning). For existing CC CTMS (Clinical Conductor) users, please use the link below to inform us of your COVID-19 studies and find out how we can help. This offer is designed to help sites conduct COVID-19 trials by eliminating unnecessary workflow barriers to delivering much needed results. If you are involved or becoming involved in COVID-19 studies, please contact us as soon as possible to avoid any startup delays.
Contact
Posted Monday, April 13
Ethical guidance and free consultancy advice during COVID-19 crisis
IntegReview IRB is providing Investigators, Sponsors/CRO and research sites unlimited free guidance and support for ongoing research during these evolving times. The IRB is offering free protocol consultation with Board Members and is convening adhoc Meetings to ensure swift ethical reviews. IntegReview IRB is providing discounted review fees for transferred studies. Our client service team is available via text/cell for rapid responses to your questions. IntegReview IRB is a woman-owned, AAHRP-accredited independent IRB. Contact: [email protected] or call the IRB at 512-326-3001
Contact
Posted Monday, April 13
CATO SMS is now offering free regulatory and clinical protocol review services for your ongoing or proposed trials
We know there are issues arising from the COVID-19 pandemic that may affect your clinical trial and cause delays. CATO SMS, a full-service global CRO, is here to support you now! We can assist in the design, refinement, or modification of development plans, accelerate clinical trial preparations, and develop insightful regulatory approval strategies. We can further use cutting-edge, proven technologies to mitigate disruptions at investigator sites and maintain clinical trial momentum. CATO SMS is a CRO with proven performance in complex research areas – immunology, pulmonology, infectious disease, oncology, orphan diseases, cell/gene therapy, and advanced therapeutics – can support you in all aspects of therapeutics development during these unprecedented times: CATO SMS is offering a free and confidential comprehensive review of your protocol synopsis and will provide you with strategic and clinical recommendations, for a limited time. We can provide input on the design, methodology, objectives, eligibility criteria, background, rationale and practical organization of your study, considering the unique properties of your compound, the competition, and the medical need it will serve. We also can offer free consultation with our Drug Development and Planning experts whose expertise spans numerous therapeutic areas.
Learn more: http://cato.com/
Contact
Posted Monday, April 13
SavantX Dataset Search and Analysis Technology Offered at No-Cost to Researchers, Scientists, and Medical Professionals
In response to the COVID-19 global pandemic, SavantX has deployed a no-cost AI-enabled web application to help medical and research professionals rapidly search, analyze and visualize the CORD-19 dataset to gain deep insight into hidden relationships within the data and answer important questions with no data science experience necessary.
Contact
Posted Thursday, April 9
As Universities and Academic Institutions Face Unique Challenges in Reporting Clinical Trials, TrialAssure Responds by Offering Free Clinical Trial Transparency Tool
TrialAssure® – a leading, global software company focused on developing clinical trial transparency tools – announced today that it will offer academic institutions free access to TrialAssure REGISTRY—the premiere clinical trial disclosure reporting application. This offer is limited to the registry configurations for ClinicalTrials.gov, the US Food & Drug Administration (FDA) clinical trial registry, and it includes one upgrade per year, keeping with technological advancements and any US regulatory updates or changes to registry requirements.
Contact
Posted Thursday, April 9
Longboat supporting research during the COVID-19 pandemic
As our colleagues in research come to terms with the short- and long-term impact of global lockdowns and restrictions on travel, we continue to support our study teams, CRAs, site staff and patients as normal during this challenging period. Longboat is offering our colleagues that are currently striving to develop a vaccine or therapy for COVID-19 our site communication platform, 21 CFR Part 11 compliant document repository, training certification and Pre-Screen Navigator features at no charge.
Contact
Posted Thursday, April 9
Dr. Reddy's Custom Pharma Services (CPS) offering technical expertise for drug discovery, development, clinical manufacturing and commercial manufacturing.
Dr. Reddy’s Custom Pharma Services (CPS) is leveraging its 20 years of experience and expertise in new drug development programs to support your drug’s journey to market. The global pandemic is adversely impacting new drug discovery, development and cGMP manufacturing. At CPS, we have two priorities: 1) the safety of our people and their families and 2)the support of our partners to provide medicines to patients. We stand committed to enable acceleration, access and affordability through discovery, biology, DMPK, clinical development and commercial manufacturing from our global locations. Strong supply chain management, digital platforms of communication and our team driven by passion would service your project.
Contact
Posted Wednesday, April 8
SiSaf Makes Its Bio-Courier® Technology Available for COVID-19 Vaccine Research
Today, CEO Dr Suzanne Saffie-Siebert, PhD, announced it is making its technology available for compatibility and feasibility studies on a not-for-profit basis to help overcome the major hurdles of developing nucleic acid based vaccines, CD8 peptides and antiviral treatments for COVID-19. The lead candidates in the race for a vaccine are nucleic acid based (including RNA and DNA vaccines). However, the significant challenges to the translation of these into vaccines include the fact that their high molecular weight and high negative charge density impair the permeation across cellular membranes, resulting in extremely low absorption and cellular expression.
Contact
Posted Tuesday, April 7
Supporting Clinical Trials at Sites Nationwide Amid the COVID-19 Pandemic
Meridian will remain fully staffed and operational throughout the COVID-19 pandemic to support the research of investigational vaccines, diagnostics, and medications intended for commercial release. All Meridian sites are working with Sponsors and CROs to ensure safety while continuing to enroll patients during the pandemic. To maintain proper social distancing, Meridian is supporting over-the-phone visits, telemedicine visits, and in-office visits with minimal exposure to others and intensified cleaning processes. Meridian has enrolled more than 25,000 subjects into vaccine and infectious disease clinical trials in the past 20 years. As a leading investigative site network for vaccine trials, the company supported a Phase I study for the Ebola vaccine when the outbreak occurred, and conducted research for Zika virus and anthrax vaccines in the past year. Headquartered in Omaha, Nebraska, Meridian operates additional sites in Nebraska (Norfolk), Georgia (Savannah), Louisiana (Baton Rouge), Maryland (Rockville), New York (Binghamton, Endwell, Johnson City, Vestal), South Dakota (Dakota Dunes), and Virginia (Norfolk). If you're interested in leveraging Meridian’s network for an infectious disease trial, contact Andrew Kimball, VP, business development at [email protected] You can learn more about Meridian's infectious disease capabilities at mcrmed.com/vaccine.
Contact
Posted Tuesday, April 7
Dedicated Clinical Research Sites with COVID-19 patients looking to enroll and support Therapeutic, Vaccine and Diagnostic Trials
For over 20 years, eStudySite has been the world’s leading clinical research sites for enrolling acute infectious disease studies. Through our unique collaboration with high volume community hospitals that see over 300k patients annually in San Diego County we can identify and enroll qualified patients as soon as they present to the Emergency Department. This model has resulted in our sites being leading enrollers in aBSSSI, CAP, cUTI & Pneumonia trials. Our IRB has provided emergency review and the turnaround has been less than 3 days. Studies can be performed in all settings from ICU to Outpatient. Happy to help with blood draw studies for our diagnostic clients as well as treatment and vaccine trials. We’re also happy to provide early protocol feedback to Sponsors wanting an “In the Clinic” perspective from a site that seen them all. We’ve already had many lessons learned and we’re happy to share so things keep moving forward as quickly as possible.
Contact
Posted Monday, April 6
MMS announces one million dollar award for pharmaceutical companies developing a vaccine for COVID-19
MMS Holdings (MMS) – an award-winning, data-focused CRO is offering a USD1M award toward the development of a vaccine for COVID-19, also known as the coronavirus. The award is being offered in the form of data and related services to qualified pharmaceutical and clinical research companies supporting the commercial development of a vaccine for approval in the United States and/or other global health authorities. To learn more about this award, please review the press release or to apply visit the online application.
Contact
Posted Monday, April 6
Health Decisions offers expertise in diagnostic and therapeutic development
We want to extend our support to companies developing solutions for the diagnosis or treatment of COVID-19. Health Decisions has expertise in the development of diagnostics for respiratory and infectious diseases, as well as the development of interventional assets. We also know that trial sponsors across the industry are working hard to navigate the complexities of continuing ongoing/planned research programs. With more than 30 years of excellence in clinical research, we can offer clinical research support and consulting to companies in need. We are eager to help address this global health crisis.
Contact
Posted Monday, April 6
Special Delivery provides free supply chain & logistics consulting for COVID-19 projects
Special Delivery is offering free supply chain and logistics consulting services to biotech and pharmaceutical companies around the world who are working on COVID-19 diagnostic tools, vaccines, and therapies. Special Delivery manages time- and temperature-sensitive shipments for the biopharmaceutical industry, including commercial supply chain solutions, clinical trials, and advanced cell and gene therapies. With more than a dozen offices in North America and Europe, along with more than 500 agents worldwide, Special Delivery serves the unique logistical requirements of a diverse and prestigious global clientele.
Contact
Posted Monday, April 6
FHI Clinical Offers Full-Service Infectious Disease CRO Support for Global Emergency Response Clinical Trials in Outbreak Settings, with Current Focus on COVID-19
FHI Clinical, Inc. is a full-scope contract research organization (CRO) that specializes in emergency response clinical trials, providing CRO services for clinical trials during outbreaks such as Ebola, Zika and influenza. We support small- and large-scale clinical trials of any phase with services including rapid site identification and start-up, protocol development, clinical monitoring, project management, regulatory submissions, pharmacy and laboratory support, site audits, data management and biostatistics. As a leading CRO for global emergency clinical trials, the FHI Clinical team is rapidly amassing expertise in COVID-19 trials with both government- and commercially-funded protocols which we use to strengthen clinical trials across our client portfolio for this crucial global health need. FHI Clinical leverages two decades of experience supporting and conducting clinical trials in the U.S. and in 50 countries around the world to ensure the safety of a clinical trial and high-quality results, regardless of contextual challenges.
Contact
Posted Monday, April 6
Medpace has a highly-experienced infectious disease team, including medical, regulatory, operational, and laboratory experts who have extensive experience designing and conducting infectious disease clinical trials
Our team is actively working with the global regulatory authorities and Sponsors responding to the COVID-19 situation. If you are developing treatments for COVID-19 and need assistance, Medpace is well-equipped to assist: 1) Speed: Our flat operating model and multi-disciplined approach are designed for efficiency 2) Site and investigator relationships: Able to leverage strong relationships to quickly assess feasibility, accelerate enrollment and move trials forward 3) Regulatory engagement: Knowledgeable in the changing regulatory landscape at local, regional, and global levels 4) Remote monitoring tools and technology: Processes and technology platforms enable remote monitoring and fast data acquisition 5) Government and research agencies: Experience and relationships allow us to collaborate with government agencies and other research institutions, such as BARDA, NIH, and Wellcome-Trust 6) Critically ill patients: Extensive experience in acute care settings with critically ill patients 7) Advanced therapies: Experience overcoming development challenges and accelerating cutting-edge technologies including cell and gene therapies 8) Testing: Medpace’s laboratories have the ability to test for COVID-19 via an FDA-approved RT-PCR assay in our US laboratory and will have the assay available in our Europe laboratory
Contact
Posted Monday, April 6
Recro Gainesville is committed to supporting new therapies and community efforts for COVID-19
To assist researchers developing therapies for COVID-19 and to aid medical workers on the frontline, Georgia-based CDMO Recro Gainesville is offering the following: 1) Virtual Meetings with our formulation, analytical, regulatory, or manufacturing experts 2) Regulatory guidance and submission support to submit new or expanded indications to the FDA for COVID-19 treatment 3) Lab space to local companies who may be facing space or funding constraints 4) PPE and lab supplies to address COVID-19 supply shortages
Contact
Posted Monday, April 6
Scout Clinical: Helping patients stick with it during the COVID-19 pandemic
Scout offers payments for local lab visits and patient reimbursement options for out-of-pocket costs associated with clinical trial participation. We can bring the patient to the site or the site to the patient. Scout offers regulatory support and guidance to comply with global data privacy laws for patient services. Available in 106 countries with payment solutions in over 100 currencies.
Contact
Posted Monday, April 6
The Central European Research Infrastructure Consortium (CERIC) has set up a dedicated Fast Track Access to a number of selected instruments
The dedicated Fast Track Access will allow access the selected instruments for research related to the COVID-19, without the necessity to undergo the regular evaluation procedure, and be scheduled within one month from the submission of the proposal, based on the feasibility evaluation performed by the facility.
Contact
Posted Friday, April 3
FindMeCure provides free access to its Feasibility and Patient Recruitment Intelligence Platform TrialHub
During the coronavirus pandemic, TrialHub supports sponsors and CROs in creating mitigation strategies for their delayed studies and brings patient recruitment back on track. It helps research professionals to get invaluable information and analysis that can save their studies. In addition, to support the Covid-19 researchers, FindMeCure team launched a separate free TrialHub Coronavirus project with all the data and analyses available on the indication. Log-in details: https://trialhub.findmecure.com/Identity/Account/Login Username: [email protected] Password: 2fightcoronavirus Project: Let's fight Coronavirus
Contact
Posted Friday, April 3
PMI Biopharma Solutions can provide fast, reliable aseptic fill/finish product manufacturing & research services to combat COVID-19
PMI Bio has the experience and tools to take your project from discovery to the clinic. Our services include target validation, fragment based high throughput screening, lead optimization, process development, and clinical aseptic fill & finish with deep expertise in microfluidization to achieve nanoparticle sizes.
Contact
Posted Friday, April 3
One Codex announces a new analysis for summarizing the detection of SARS-CoV-2 in samples is available at no charge
In an effort to contribute however we can, our team has been working to make analysis of genomics data from COVID-19 samples simpler, more accessible, and easier to share with the broader community. Today, we’re announcing a new analysis summarizing the detection of SARS-CoV-2 in samples that contain evidence of the virus. We’re making this analysis available at no charge and it will be automatically run on any samples in which we detect SARS-CoV-2. In return, all that we ask is that you share relevant metadata and the consensus sequences from your samples (and we’ll help enable that).
Contact
Posted Friday, April 3
Mondosano is offering patient recruitment services as well as patient outreach campaigns within the DACH area
Mondosano is a patient platform that supports patient recruitment for clinical research. Through our database, we offer direct contact to over 80,000 patients and another 10,000 patients in moderated communities. Here, patient populations can be targeted through patient awareness campaigns or patients can be screened by our patient advisors (former MFA's, nurses etc.) and referred directly to a study center in the context of a clinical trial.
Contact
Posted Friday, April 3
ERT offering At-Home ECG Assesments
ERT’s At-home ECG solution enables clinical researchers to continue assessing the cardiovascular risk of new medical treatments, even while patients are adhering to local and global stay home mandates. Since every new compound requires cardiac safety assessment during development, ERT is enabling At-Home ECG monitoring. ERT’s infrastructure enables the normalization and precise over-read of ECGs captured digitally via ERT’s provisioned devices or on paper via site-owned equipment. Investigative site personnel conducting home visits can capture this important safety data and yield comparable values, regardless of how the data was captured. ERT scientists are available to consult with researchers on how ‘at-home’ ECG readings can ensure patient safety while keeping both their current and new trials on track
Learn more: www.ert.com
Contact
Posted Thursday, April 2
CRScube has joined the fight against the Coronavirus pandemic by providing free access to its Electronic Data Capture (EDC) system for COVID-19 research projects
CRScube has joined the fight with academic, government, non-profit research organizations, and CROs by providing free access to CRScube's Electronic Data Capture (EDC) system with our Risk-based Monitoring module (RBM) for COVID-19 research projects worldwide. Additionally, CRScube will make available its turnkey solution with electronic Case Report Forms (eCRFs) based on the WHO standard NCOV-CRFs, to capture standardized data allowing organizations an effortless and rapid startup.
Contact
Posted Thursday, April 2
Biochannel Partners launches directory of manufacturers and distributors of laboratory products granting free access to companies who are supplying products which can help with Covid-19 pandemic
BioChannel Partners Ltd has developed a directory of manufacturers and distributors of laboratory products with a view to facilitating partnerships for global distribution. We developed https://covid-19.biochannelpartners.com to offer free access to the directory for companies who are supplying products which can help with Covid-19 pandemic. E.g. Manufacturers looking for distributors in export markets, Distributors who are looking for products to supply locally, Manufacturers who can supply or need products to ramp up production. The directory includes companies who supply e.g. diagnostic kits, reagents for the manufacture of the kits, laboratory instruments and consumables.
Contact
Posted Thursday, April 2
Quotient Sciences is dedicated to accelerating the development of new COVID-19 drugs for patients around the world
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry and we are here to support you, in the development of novel COVID-19 treatments. Our unique Translational Pharmaceutics® platform is proven to accelerate drug development timelines by 12 months and we have helped develop over 1,000 molecules at all stages of drug development. Let us support the fight to bring a treatment to the market, fast. For more information please contact [email protected]
Contact
Posted Thursday, April 2
Synteract leverages extensive infectious disease and vaccine experience while actively working on new COVID-19 treatment solutions
Synteract understands the complexities of infectious disease and vaccine trials, from accelerated patient enrollment to maintaining specimen integrity to ever-changing timelines. Actively working on new COVID-19 studies; both vaccine for healthy volunteers as well as treatment for patients with confirmed coronavirus infection, Synteract remains committed to business continuity while ensuring the safety of patients, employees, and partners.
Contact
Posted Thursday, April 2
COVID-19 dataset pipeline now globally available via Lifebit CloudOS
Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, announced it is providing its premium Lifebit CloudOS license free to all researchers and teams working on COVID-19 efforts, including diagnostics, treatments, and vaccines. The Lifebit CloudOS Team license provides a team workspace for seamless collaboration and project sharing. Users can manage data, projects, access privileges, spending limits, reports, and more with advanced tools. Users also have access to the complete Lifebit CloudOS Marketplace and powerful APIs. To further accelerate progress and help researchers save time in combating COVID-19, Lifebit also announced it has made globally available the dataset for SARS-CoV-2 from NCBI. The dataset consists of viral sequence data for SARS-CoV-2 and includes all Next Generation Sequencing runs for SARS-CoV-2 from the Sequence Read Archive (SRA), associated metadata, and the virus reference genome.
Contact
Posted Thursday, April 2
Castor launched a COVID-19 monitoring and research platform and is supporting over 180 trials free of charge
Castor joined the global fight against the Coronavirus in February by offering free access to its electronic data capture (EDC) system for all COVID-19 research projects. Castor developed ready for use eCRFs based on the WHO standard CRFs to help researchers start their study or registry in less than an hour. As of May 1, Castor is supporting more than 180 COVID-19 studies across 15 countries. This includes one of the world’s largest randomized controlled trials on this disease. Castor also launched a COVID-19 monitoring and research platform to facilitate the rapid deployment of trials to test Coronavirus vaccines and COVID-19 treatments. The platform includes an online enrollment portal for patients, an eConsent module, and a Symptom Tracker app, all integrated with Castor's EDC system
Contact
Posted Thursday, April 2
Free Quantum Cloud Access for Global Response to COVID-19
As you can imagine, optimization is a useful approach to solving many of the challenges presented by COVID-19, from the problem of getting resources to people stuck in quarantine, to simulating protein folding, and beyond. We are making available free Leap resources to help fight COVID-19. This includes time on our quantum processing units (QPUs) and hybrid solvers, as well as access to a wealth of other resources to help you get started, including our online integrated development environment (IDE), community discussion forums, learning materials, and more. Currently, this special COVID-19 Leap access is offered to users in those countries where Leap access is already available.
Contact
Posted Wednesday, April 1
LakePharma has developed a range of SARS-CoV2 related reagents
To help combat the current pandemic, LakePharma is making reagents and assays available to the biotech community for rapid antibody and diagnostic development against SARS-CoV2. LakePharma is hosting a webinar “Part 2: LakePharma Reagents & Assays for COVID-19 Antibody Response” on May 14, 2020 at 11AM EST. The purpose of the webinar is to establish awareness and connections so that useful reagents can be developed and distributed quickly and efficiently. Register now to learn more about LakePharma’s initiatives against COVID-19, click the link below next to learn more:
Contact
Posted Wednesday, April 1
Elsevier Launches Veridata™ Electronic Data Capture (EDC) and Offers Free Access to Help Researchers Studying COVID-19
To assist researchers working to develop vaccines and other therapies for COVID-19, Elsevier has pledged to make Veridata EDC available for free. Interested clinical researchers can contact Elsevier customer support via e-mail at [email protected] and apply for a demo account. Following the necessary compliance training, they will receive a free 12-month license. Veridata EDC provides clinical researchers with secure and compliant electronic data capture to ensure that the rights, safety and well-being of clinical trial participants are protected. Its intuitive user interface means researchers can quickly input, monitor and run reports to collect accurate and reliable subject data for analysis.
Contact
Posted Thursday, April 2
Datatrak to Provide Virtual Collaboration & EDC Platform for Free for COVID-19 Trials
Datatrak, a worldwide Software-as-a-Service (“SaaS”) provider and innovation leader of cloud-based technologies for the life sciences industry, today announced they are waving our Datatrak Enterprise Cloud EDC software license fees for COVID-19 trials.
Contact
Posted Wednesday, April 1
Sinobiologial has developed an antigen Detection kit for SARS-CoV-2
In order to control the global outbreak of COVID-19, extensive research efforts have been put into the development of vaccines and inhibitors against the culprit virus, SARS-CoV-2 (formerly 2019-nCOV). There is a critical need for assays that can allow rapid quantification of the viral antigens. Sino Biological has released the world-first ELISA kits for the detection of SARS-CoV-2 N and S proteins.
Contact
Posted Wednesday, April 1
TrialCard vitrual services aligning with COVID-19 research efforts
TrialCard's services that align with COVID-19 research efforts: 1) Social distancing, by allowing study participants to pick up commercially-available medications and supplies at a local retail pharmacy’s drive-thru window 2) Stay in place sheltering, by utilizing a retail mail-in pharmacy to ship the same supplies directly to the patient’s home 3) Enhanced patient access/affordability, by providing concomitant medication discounts or free product for patients in financial need. Indigent clinical study participants who forego needed medication or supplies can put themselves at a safety risk and increase the likelihood of adverse events, which can negatively impact the study.
Contact
Posted Tuesday, March 31
Data MATRIX to offer free Electronic Data Capture (EDC) for all COVID-19 trials in 2020
In response to the global outbreak of the pandemic, the clinical data management software developer will provide its trademark validated all-in-one SaaS solution for clinical trials at zero cost for researchers to be able to obtain clean data and speed up the trials of such a vital value to the global community.
Contact
Posted Tuesday, March 31
ARG is offering free general feasibility guidance as well as discounts on our full suite of services
ARG is offering free general feasibility guidance as well as discounts on our full suite of services. Consistent investments in technology and communications over time have led to cloud-based systems that will allow us to remotely perform all project management, data management, statistics, medical monitoring, and drug safety tasks--in start-up, maintenance, and close-out. These capacities are valuable during this challenging period.
Contact
Posted Tuesday, March 31
Expedite IRT launch for COVID-19 trials with the strength of endpoint’s Pulse®& Partner network
Endpoint is prepared to rapidly deploy IRT systems and meet the challenge of enabling virtual trials with direct to patient shipping and telemedicine to get therapies to patients faster.
Contact
Posted Tuesday, March 31
Worldwide Clinical Trials offers virtual trials, in-home care and travel support.
Depending on your unique trial requirements, our teams will work with you to develop business continuity plans to enable dependable delivery of our commitments. These may include: Virtual Centralized Monitoring, Flexible Patient Care - In-Home Care, Virtual Investigator Meetings, Travel Support and Logistics.
Contact
Posted Tuesday, March 31
ATUM provides COVID-19 diagnostic and therapeutic developers free access to its protein synthesis platform
ATUM is providing free access to its Leap-In Transposase® protein production platform to commercial and academic laboratories developing diagnostic tools, vaccines and new protein-based therapies in support of the global COVID-19 response. With a wide variety of viral proteins, antibodies, interleukins and related protein molecules currently under evaluation across COVID-19-related clinical trials, ATUM's biological Leap-In platform enables the rapid production of commercial-grade protein from gram to kilogram levels. The efficient cell-based production of these proteins is essential to the scale-up of manufacturing vaccines, protein-based therapeutics and diagnostic tests.
Contact
Posted Tuesday, March 31
PRA Health Sciences launches COVID-19 monitoring program
PRA Health Sciences announces commercial availability of the COVID-19 Monitoring Program, a mobile app-driven, tiered initiative that allows employers, payers, providers and health systems to track the health and wellbeing of individuals who may be asymptomatic, exposed or diagnosed with COVID-19 during the pandemic.
Contact
Posted Tuesday, March 31
OneThree Biotech is offering free toxicity screening for small molecules treating COVID-19
OneThree Biotech is offering free toxicity screening for academic or medical researchers working on new drugs to treat COVID-19
Contact
Posted Tuesday, March 31
Datacubed Health offering free access to their virtual clinical trials platform Linkt for Covid-19 studies
Datacubed Health is offering free access to Linkt, its virtual clinical trials platform. The Linkt platform captures patient data through the use of smartphone apps, web interfaces, wearables, and other digital tools for remote enrollment and engagement in clinical studies.
Contact
Posted Tuesday, March 31
Nubilaria offers its EDC platform ACTide for free for researchers working on COVID-19 treatments
Nubilaria offers its electronic data capture (EDC) platform 'ACTide' free-of-charge to researchers working on COVID-19 treatments. Among its features, the platform allows for remote morning of patients and can be applied on intervention and real-world trials as well as epidemiological survey.
Contact
Posted Tuesday, March 31
Clinone is offering patient recruitment services at no cost
Aiming to support the ongoing clinical research on coronavirus vaccines, ClinOne will be offering its patient recruitment services free-of-charge. The offer will include its site-facing (Core and 'Schedule of Events Manager) modules, as well as its patient-facing modules including CTC Digital Concierge and eConsent
Contact
Posted Tuesday, March 31
Biopharma Services donates clinical resources, scientific expertise for Coronavirus vaccine research
With their state-of-the-art Phase 1 clinical infrastructure and expert team of scientific and medical personnel, BioPharma is donating its World Health Organization (WHO) approved facility for coronavirus COVID-19 vaccine research and treatments. We invite all biotech companies woImproving human health through more predictive and relevant rodent modelsImproving human health through more predictive and relevant rodent modelsrking to create a vaccine for the developing global crisis of this novel coronavirus to contact us to discuss how BioPharma’s capabilities and resources can be mobilized to accelerate the development of therapeutic treatments and vaccines.
Contact
Posted Monday, August 24
AltraBio: statistical analysis from omics, cytometry and medical data and help for designing and understanding them. AltraBio works with both COVID-19 related studies and standard studies
During the COVID-19 crisis, AltraBio is offering consultations and advices on your experimental design and tools to use for an optimal exploitation of your samples, for COVID-19 and regular studies In the context of COVID-19, AltraBio would like to highlight its solution for gating automation. Indeed, thanks to its expertise on machine-learning, AltraBio developed a specific approach allowing the automation of the treatment of cytometry data for immunophenotyping. The use of this approach will allow you to increase the robustness of your results as well as saving time and cost for these analyses. AltraBio provides the complete range of up-to-date data analysis services relevant to biological data: data quality audit, data-mining; power estimation, survival estimation, log rank test, Cox model, complex statistical models; machine learning methods; database design and implementation.
Contact
Posted Thursday, August 20
COVID19 whole genome sequencing kits, free bioinformatics and discounted qPCR test kits
We provide discounted qPCR kits NGS kits for detection and sequencing of COVID19 samples. All kits are designed to be simple to use, highly sensitive and massively reliable. Alongside our Next Generation Sequending kit we also provide fast (10 minute) free of charge bioinformatics for processing sequencing data.
Contact
Posted Friday, July 31
Craig Serra is offering pro-bono consultancy in the clinical development operations and technology area
Craig has been in the industry for 18+ years in clinical development operations in both the pharma and CRO space. With knowledge spanning functions such as data operations, monitoring (remote and risk based), and clinical technology, Craig can help with overarching strategy, vendor selection, and tactical implementation. Even just as a person to bounce some ideas off of, Craig is happy to help COVID-19 researchers any way he can.
Contact
Posted Tuesday, July 28
Azur Clinical Services offers free statistical consulting and discounted offerings for COVID-19 efforts
• Azur Clinical Services is offering the following services for COVID-19 research • Statistical Consulting : Designing adaptive study, expert opinion on data handling under pandemic situation, Sample size estimation, Understanding and evaluating treatment based effect, Covid impact analysis, Sensitivity analysis for covid impacted clinical result, Handling missing and NR (due to covid and / or non-covid) values, complete statistical solutions. • Handson statistical work : Sample size calculation, Protocol inputs, SAP, TLF mock shells, statistical analysis, SAR or CSR input
Contact
Posted Wednesday, July 15
RUCDR Infinite Biologics supports COVID-19 diagnostic testing, sample management, Multi-omic analytical services, biobanking and advanced cells line services
As the world’s largest university-based biorepository, RUCDR has been perfecting the science of biobanking, bioprocessing and analytics since 1999. As experts in sample management strategies we were quick to innovate with the first FDA approved Saliva Collection device which now includes at-home saliva sample collection with our healthcare partners. As a Next Generation Central Laboratory, we offer a bespoke and tailored service transforming every sample into a renewable resource for life sciences diagnostic, discovery, and development. • Sample Management Strategies • High Throughput DNA/RNA extraction • Multi-omic Analytical Services • Advanced Cell Culture & Stem Cell services • Bioinformatics & Analytical services • Biobanking
Contact
Posted Tuesday, June 30
Free Clinical Trial SaaS to help Sponsor and Academic Clinical Operations/Research teams stay hyper organized and informed about their clinical trial subjects
We’re offering a free subscription to our Clinical Trial SaaS (software-as-service) for the lifetime of a COVID-19 trial. Offer expires after it has been redeemed for two clinical trials. Our cloud-based Clinical Trial SaaS was designed to help Sponsor and Academic Clinical Operations/Research teams quickly consolidate, organize, and meaningfully report on all their subjects’ operational data without complex integrations. Teams no longer need to rely on Excel or navigate to separate data sources/systems. All our SaaS subscriptions include custom protocol-specific setup and dedicated support.
Contact
Posted Monday, June 15
Sanguine Biosciences provides biopharma researchers with non-invasive samples from recovered COVID-19 patients
Sanguine Biosciences, a California-based technology company focused on patient engagement and digital health, connects the researchers that need access to non-invasive biospecimens with the patients that would qualify to be test subjects. Sanguine’s concierge service provides mobile health care workers to visit the patient in the comfort of their own home.
Contact
Posted Friday, May 29
Interek provides support for companies working on COVID-19. We provide a wide range of services for Vaccine & Therapeutic Development
Providing COVID-19 Vaccine and Therapeutic testing and development outsourcing solutions. Enabling your business to progress the fight against COVID-19 through GLP, GCP and GMP vaccine or therapeutic support including bioanalysis, characterization, release testing and auditing. Intertek can design and deliver the highest quality, phase appropriate characterisation and QC/release testing solutions. With proven scientists who have contributed to the development of existing flu vaccines, our solutions are built on experience, from early stage formulation development, clinical trials to manufacturing and beyond. We work across many modalities including small molecule, viral vector products, oligonucleotides, mRNA, recombinant and natural proteins, inhaled or nasal drugs, lipid nanoparticle or liposome encapsulated products and so whatever your modality, we have the expertise ready to assist you.
Contact
Posted Monday, May 25
Unique AI analytics platform offered to medical research community
PrecisionLife is offering free use of its unique AI analytics platform and support from its data and biomedical science teams to the on-going collaborative efforts of the medical research community in the fight against COVID-19 coronavirus.
Contact
Posted Monday, May 25
MyCRO Offers Discounted Site Management, Feasibility, Logistic Support and Central Management in Turkey to all COVID 19 related trials
Founded in Ankara, MyCRO’s mission is to provide the highest quality at every stage of clinical research. We are bringing to you our 8 years of clinical research logistic support and 10 years of experience in Clinical Research Management in Phase I-IV, Observational, and Medical Device studies. We conduct studies in more than 20 cities which means we have a wider range than most of the CROs in Turkey. Our primary advantage on the other CROs in Turkey in the situation of initiating a COVID-19 study. We can help with the process from A to Z after a Sponsor decides to open a new site in Turkey or initiate a new study for COVID-19. We will be supporting them by starting to prepare the EC and MOH files, doing the submissions, selecting the sites as well as finding the most successful and eager PIs, doing SIVs, providing and training the site Staff, etc. Hence, we may be the best option in Turkey.
Contact
Posted Friday, May 22
Full-service CRO with extensive vaccine and infectious disease experience
ProTrials’ senior management has been monitoring the global COVID-19 pandemic with a focus to protect study patients and our employees, while ensuring business continuity with our sponsor partners. We continue to monitor the latest guidance from international health organizations and the evolving impact of the pandemic, and we recognize that your project may have unique considerations. ProTrials has supported vaccine and infectious disease trials for 24 years and more than 70% of our clinical staff have related trial experience. We have managed vaccine trials focused on flu, HIV, meningitis, oncology, hepatitis B, smallpox, anthrax, among others, and are actively preparing to support new trials focused on COVID-19. Working with our sponsor partners to implement programs with virtual patient assessments and remote trial management activities is the new normal.
Contact
Posted Friday, May 22
Global COVID-19 clinical trial tracker launched by Cytel
Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders who need to understand the complex dynamics of the global response to finding a solution to the COVID-19 outbreak.
Contact
Posted Tuesday, May 19
Non-GMP small molecule development services to expedite potential COVID-19 treatments
CatSci Ltd is a leading process Research and Development CRO for the pharmaceutical industry. We work with small, mid-sized, large and virtual pharma, applying our expertise in delivering drug discovery and development projects to develop manufacturing processes for small molecule APIs. With the outbreak of COVID-19, we are offering a host of small molecule chemistry services including route scouting and selection, process design, scale-up and non-GMP material supply at cost in order to help turn your small molecule asset into a potential COVID-19 medicine. We will strive to ensure your therapeutic can be manufactured in an economically viable and environmentally sustainable manner, and its manufacturing control strategy can be implemented over the lifecycle of the medicine.
Contact
Posted Thursday, May 14
In vivo / in vitro immunology studies and molecular testing for Sars-CoV-2 infectivity
Texcell can test the infectivity of Sars-CoV-2 on living cells, to evaluate the potency of active molecules to block virus entry or virus replication, for the detection of immuno-active patient sera.
Contact
Posted Thursday, May 14
Noble.AI to provide free AI tools to scientific community to speed discovery of a Covid-19 cure
Noble.AI, an industry leader in AI powered software that accelerates science and helps researchers make more important discoveries faster, announced that today they are launching the Immunity Initiative – www.immunity-initiative.org – providing free cloud-based AI models and data to research labs and scientists around the world to speed discovery of the most promising treatments and cures for Covid-19.
Contact
Posted Tuesday, May 12
Coronavirus custom cloning and cell line services for preclinical and clinical COVID research
VectorBuilder is the world's leading provider of vector construction and virus packaging services. Our highly intuitive online design tool on VectorBuilder.com provides a user-friendly workflow to design your desired vectors with just a few mouse clicks and all for free. Our ever-expanding collection of backbones, promoters and ORFs ensures you save money and valuable time compared to Do it Yourself (DIY) cloning. All vectors come with a 100% sequence guarantee and VectorBuilder is also a source for premium downstream services including library generation, targeting vector and CRISPR vector design as well as BAC modification. With the outbreak of COVID-19, we are now also offering a host of services for preclinical and clinical CoV-2 research. VectorBuilder’s flexibility offers custom vector design at its best and fastest so you can focus more on critical experiments and data analysis.
Contact
Posted Friday, May 8
seQure offers pharmacovigilance support in clinical trials related to a potential COVID-19 treatment
seQure is a niche service provider in the Life Sciences sector offering expert pharmaco- and device vigilance, quality assurance, and regulatory solutions to drug and device companies. We have exceptional expertise in vigilance, with a team that boasts more than 25 years of experience. We are already involved in a clinical trial as a pharmacovigilance partner related to a potential COVID-19 treatment. Our pharmacovigilance team guarantees impeccable quality and uncompromising attention backed by years of industry experience.
Contact
Posted Wednesday, May 6
Reduced rates & free feasibility for COVID-19 trials from Wuxi Clinical
In response to COVID-19, WuXi Clinical has developed a comprehensive network of investigators capable and willing to conduct clinical trials across all phases in both the USA and China. We will waive all feasibility costs for any contracted COVID-19 study beginning in 2020. Additionally, we will provide discounted rates for all contracted services on these trials.
Contact
Posted Wednesday, May 6
Poseidon CRO offers its expertise in North Africa, Central, and Eastern Europe to all COVID 19 related trials for IVD/vaccines/drugs/medical device
Poseidon CRO has a wide regional reach in North Africa, Central, and Eastern Europe, providing a large spectrum of services to the drug development, medical device, in-vitro diagnostics industries. We have robust expertise in the fields of small molecules, IVD validation, biological, and biosimilars clinical testing. Our network of sites and experienced professionals can be immediately involved in research projects including COVID 19 patients and give their expertise in the validation of proposed solutions. We are open to collaborate with other companies/sponsors/Health organizations offering: 1) Expedite regulatory approvals 2) Implementation and follow up of virtual trials 3) Optimization of patient enrolment and Site management 4) Assurance of business continuity regarding clinical trial logistic support 5) Adequate project management insuring optimal sponsor oversight 6) Reach out to us so we gather our efforts to bring in to life innovative and pertinent solutions to cope with these unprecedented challenges.
Contact
Posted Monday, May 4
Ready to contribute to the global community - Japanese phase 1 site for COVID-19 studies
Supporting clinical studies related to diagnostics, novel/repurposed drugs, and vaccines that focus on bringing an end to the global COVID-19 pandemic. 1) Accelerated (<30 days) clinical trial notification timeline to start FIH studies of COVID-19 candidate products 2) Expedited IRB application reviews for COVID-19 trials 3) Precision Bronchial Micro Sampling (BMS) assessment to evaluate the effective delivery of target medicines to lung cells 4) Extensive Vaccine Study* experience with both young and elderly male/female subject groups, as well as children (*over 1,000 subjects per study) 5) Supported expertise of SOUSEIKAI’s Clinical Epidemiology Research Center, whose director was a former member of the WHO Strategic Advisory Group of Experts (SAGE) Working Group for H5N1 influenza vaccines.
Contact
Posted Friday, May 1
Site contract negotiation executed quickly and efficiently
Triacle is a specialist consultancy focused exclusively on site contract negotiation. Our pan-European team of highly experienced negotiators ensure site contracts are finalised quickly and efficiently. At this time of heightened activity, having a team of dedicated, multilingual experts in site contract negotiation and execution working with you makes a real difference.
Contact
Posted Friday, May 1
PYRAMID Laboratories, Inc. is a CMO able to provide fill finish services for injectable drug products, we offer 10% discount on our services for products related to COVID-19
PYRAMID Laboratories, Inc. is a CMO focused on parenteral drug products, offering a comprehensive pipeline of services. Established in 1988 in Southern California, we offer aseptic vial and syringe filling, as well as lyophilization capabilities, for both Clinical and Commercial products. Our laboratory offers product development and analytical capabilities performing dozens of methods in a cGMP/GLP setting. For over 30 years, we have provided clients with Top Quality services assuring that their critically important parenteral products reach patients in need.
Contact
Posted Thursday, April 30
PRG International Site Network supporting sponsors and CROs on vaccine and therapeutic treatments against COVID-19
Physicians Research Group (PRG) is a leading international research management organization and site network. We are headquartered in Tempe, Arizona, and have locations throughout the US and partnerships with sites in; Australia, Canada, South Africa, South America, and New Zealand. PRG and our partners have extensive experience in phase I-IV trials, including vaccines and infectious disease indications. PRG Provides: Centralized HIPPA compliant study systems Centralized contracting and budgeting across all of our site network (including international locations) - reducing overall study costs Virtual subject visit capable Remote Monitoring and real-time data sharing Inpatient, outpatient, and hospital locations Access to over a 2M patient population PRG is committed to providing high-quality research and development data on potential treatments and vaccines against COVID-19. We are here To learn more about how PRG can help you in the fight against COVID-19, contact Robert Wallace, President and CEO at [email protected]
Contact
Posted Tuesday, April 28
Prepare for COVID-19 trials: Free virtual trial training program available to any clinical research professional worldwide
For clinical research sites: VirTrial is offering a free four-module training program covering general telemedicine etiquette and guidelines, as well as how to utilize the VirTrial Virtual Care Management (VCM) platform. The program is available to any clinical research professional worldwide to aid in their preparation for COVID-19 trials or any other trial that requires remote visits. Upon completion, VirTrial will provide a Virtual Trial Capable certificate and digital badge that can be shared online to highlight to sponsors and CROs that they are prepared to conduct hybrid decentralized clinical trials. For Sponsors/CROs: VirTrial is offering the industry's most robust telemedicine platform available (utilized for 7 years in healthcare delivery) customized for clinical trials. Through the secure platform we can offer a complete virtual experience for both patients and monitors needing to interact with their study site.
Contact
Posted Monday, April 27
Offering COVID-19 related probes, genes, and protein products separately and as part of our convenient SARS-CoV-2 Real-Time RT-PCR Detection Assay Kit.
Since the outbreak of COVID-19, Synbio Technologies has set up a special coronavirus emergency project team, working against time to produce virus-related probes, genes, and protein products. We are currently providing comprehensive COVID-19 DNA solutions and working with our clients and partners from hospitals, scientific research institutes, and enterprises to fight the disease.
Contact
Posted Thursday, April 23
Providing sites for COVID-19 trials and global crisis communication solutions
ISS has sites located across North America, including several in highly impacted areas, that are fully operational and equipped to conduct COVID-19 vaccine, treatment, and diagnostic studies. To assist with these critical, fast-paced studies, our sites are expediting contracting (avg 3-5 BD) and activation timelines (1-2 weeks). Capabilities: 1) Testing centers for COVID-19 in several states 2) Hospitals with access to severe and acute patients 3) Facilities that meet COVID-19 isolation requirements 4) Access to diagnostic machines that can provide rapid positive or negative diagnoses (within 5 to 15 minutes) 5) Full capability to conduct virtual visits or utilize telemedicine
Contact
Posted Tuesday, April 21
Prepared & equipped to join the battle against COVID-19
DM Clinical Research (DMCR) has led with an agile, carefully-laid plan to deal with the COVID-19 Pandemic. With patient and staff safety and well-being as the one priority, avenues to minimize contact while continuing to keep protocol schedules on track has been the focus. DMCR's network of sites remain fully operational by innovatively leveraging econsent, eSource, telemedicine platforms, “drive-thru” visits, and site- to-subject drug transport. In addition, DMCR has been in close collaboration with Sponsors seeking site input on adapting protocols. To learn more about DMCR, site capabilities, and opportunities to partner, please contact Marianne Tadros, Director of Corporate Development, at: [email protected]
Contact
Posted Tuesday, April 21
ERT delivers actionable insights to identify COVID-related clinical trial risks
ERT’s complimentary COVID-19 Dashboard integrates data on coronavirus infection rates in geographic areas surrounding study investigative sites, so sponsors can identify and proactively intervene where patient and site compliance to study protocols may be at risk. The Dashboard helps sponsors identify areas of imminent risk caused by reduced patient site visits, enabling them to intervene and keep patients engaged throughout clinical trials. Study-specific reports present convenient views of COVID-19 cases in relation to study site locations, flag sites and patients with potential device/data risks, and enable a targeted intervention approach toward real-time study monitoring to ensure data quality, regardless of patient access to investigative sites.
Contact
Posted Friday, April 17
Illumina makes software toolkit available free of charge to support worldwide efforts to combat COVID-19
Illumina, Inc. announces the Illumina SARS-CoV-2 Data Toolkit, a new suite of data analysis tools and workflow functionality for researchers working with the virus using next-generation sequencing (NGS). The toolkit makes it easier for researchers to detect and identify the SARS-CoV-2 viral sequence in their samples and contribute their findings to critical public databases. Illumina is making the toolkit available at no cost to the global research community in support of efforts to combat the pandemic.
Contact
Posted Friday, April 17